Investors

Half year Median Technologies liquidity contract statement contracted with AUREL BGC Company

15 July 2019, Sophia Antipolis, France

Press Release – For immediate release – 5:45 PM CEST

Half year Median Technologies liquidity contract statement contracted with AUREL BGC Company

Under the liquidity contract entrusted by Median Technologies to AUREL BGC, the following resources were listed in the liquidity account as of June 30, 2019:

  • €104,740.61
  • 43,401 shares
  • Transactions during the first half 2019:
BUY 47,949 shares  €70,887.89 126 transactions
SELL 54,182 shares  €81,725.67 126 transactions

For information, as of December 31, 2018, the following resources were listed in the liquidity account:

  • € 93,902.83
  • 49,634 shares

About Median Technologies

Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and iBiopsy®, our AI-powered software as medical device help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.

Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label “Innovative company” by the BPI and is listed on Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME), is part of the Enternext® PEA-PME 150 index and has been awarded the Euronext European Rising Tech label. For more information: www.mediantechnologies.com

Contacts

Median Technologies

Emmanuelle Leygues
Head of Corporate Marketing and Financial Communications
+33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com

Actifin  (Investors)

Ghislaine Gasparetto
+33 6 21 10 49 24
ggasparetto@actifin.fr

Alizé RP  (Press)

Caroline Carmagnol
+33 6 64 18 99 59
median@alizerp.com